Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Short-term testing--are we looking at wrong endpoints?

C Ramel1

  • 1Department of Genetic and Cellular Toxicology, Wallenberg Laboratory, University of Stockholm, Sweden.

Mutation Research
|May 1, 1988
PubMed
Summary

Current short-term tests for carcinogenicity lack crucial genetic endpoints. New assays incorporating advanced genetic and molecular technologies are needed for more accurate cancer risk assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peculiarities in PMC Meiosis of Pisum sativum.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Quantitative sensory testing of intraoral open wounds.

International journal of oral and maxillofacial surgery·2012
Same author

Hypergonadotropic hypogonadism in a patient with inv ins (2;4).

International journal of andrology·2007
Same author

Small supernumerary marker chromosomes--progress towards a genotype-phenotype correlation.

Cytogenetic and genome research·2005
Same author

Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation.

Gut·2001
Same author

Environmental radioactivity, population exposure and related health risks in the east Baltic region.

Scandinavian journal of work, environment & health·1999

Area of Science:

  • Genetic Toxicology
  • Carcinogenesis Research
  • Molecular Biology

Background:

  • Short-term tests for carcinogenicity have historically relied on empirical correlations with animal studies.
  • This approach was necessary due to limited understanding of the specific genetic alterations driving cancer.
  • Emerging knowledge of oncogene activation and other genetic changes in carcinogenicity necessitates a strategic re-evaluation of testing.

Purpose of the Study:

  • To highlight the limitations of current short-term testing batteries that focus mainly on point mutations and chromosomal aberrations.
  • To emphasize the importance of incorporating less-studied genetic endpoints in carcinogenicity assessment.
  • To advocate for the development of advanced assay systems aligned with current understanding of cancer-causing genetic alterations.

Main Methods:

  • Review and interpretation of existing data on genetic alterations involved in carcinogenicity.
  • Analysis of the scope and limitations of current standard genetic toxicology assays.
  • Consideration of novel genetic and molecular technologies for identifying genetic changes in tumors.

Main Results:

  • Current short-term tests overlook critical genetic endpoints such as gene amplification, transpositions, hypomethylation, polygene mutations, and recombinogenic effects.
  • Indirect mechanisms, including radical generation and nucleotide pool imbalance, significantly contribute to chemical carcinogenicity and co-carcinogenicity.
  • Modern molecular technologies offer new possibilities for detecting genetic alterations relevant to cancer induction.

Conclusions:

  • Future genetic toxicology testing strategies must integrate a broader spectrum of genetic endpoints.
  • Developing sophisticated assay batteries that reflect actual genetic alterations in cancer is crucial for accurate risk assessment.
  • Regulatory flexibility is essential to facilitate the adoption of these advanced testing approaches.

Related Experiment Videos